North America holds a significant share of the aciclovir market due to advanced healthcare systems, rising incidence of viral infections, and strong availability of prescription antiviral drugs. The region also benefits from increasing healthcare expenditure, continuous pharmaceutical innovation, and growing emphasis on timely treatment, supporting steady market growth throughout the forecast...